CN110730690A
|
|
Systems, devices, and methods for microfluidic analysis
|
EP3574308A1
|
|
Solution-based plasmon specific-binding partner assays and metallic nanostructures
|
MX2018016334A
|
|
Devices with modified conduits.
|
EP3331818A1
|
|
Signal amplification in solution-based plasmonic specific-binding partner assays
|
TW201614219A
|
|
Signal amplification in plasmonic specific-binding partner assays
|
US2015204868A1
|
|
Peptides, devices, and methods for the detection of Anaplasma antibodies
|
US2015285797A1
|
|
Compositions and methods for identifying Ehrlichia species
|
CA2886989A1
|
|
Peptides, devices, and methods for the detection of ehrlichia antibodies
|
RS58168B1
|
|
Signal amplification immunoassays
|
US2013115634A1
|
|
Peptides and methods for the detection of lyme disease antibodies
|
KR20130032895A
|
|
Rotors for immunoassays
|
CA2798456A1
|
|
Validation of point-of-care test results by assessment of expected analyte relationships
|
KR20120107497A
|
|
Novel assays for detecting analytes in samples and kits and compositions related thereto
|
CN102834411A
|
|
Peptides, devices, and methods for the detection of ehrlichia antibodies
|
KR20120096932A
|
|
Peptides and methods for the detection of lyme disease antibodies
|
US2010233708A1
|
|
Split flow device for analyses of specific-binding partners
|
CA2742678A1
|
|
Lateral flow strip assay with immobilized conjugate
|
WO2010006201A2
|
|
Methods of reducing non-specific interaction in metal nanoparticle assays
|
WO2009117510A2
|
|
Multi-wavelength analyses of sol-particle specific binding assays
|
US7177767B2
|
|
Systems and methods for the detection of short and long samples
|